Nucleoside analog ARC targets Mcl-1 to induce apoptosis in leukemia cells.
作者信息
Bhat U G, Gartel A L
出版信息
Leukemia. 2010 Apr;24(4):851-5. doi: 10.1038/leu.2010.3. Epub 2010 Feb 18.
Abstract
摘要
相似文献
1
Nucleoside analog ARC targets Mcl-1 to induce apoptosis in leukemia cells.
Leukemia. 2010 Apr;24(4):851-5. doi: 10.1038/leu.2010.3. Epub 2010 Feb 18.
2
ARC synergizes with ABT-737 to induce apoptosis in human cancer cells.
Mol Cancer Ther. 2010 Jun;9(6):1688-96. doi: 10.1158/1535-7163.MCT-09-0919. Epub 2010 Jun 1.
3
Synergistic antitumor activity of gemcitabine and ABT-737 in vitro and in vivo through disrupting the interaction of USP9X and Mcl-1.
Mol Cancer Ther. 2011 Jul;10(7):1264-75. doi: 10.1158/1535-7163.MCT-10-1091. Epub 2011 May 12.
4
Tipping the Noxa/Mcl-1 balance overcomes ABT-737 resistance in chronic lymphocytic leukemia.
Clin Cancer Res. 2012 Jan 15;18(2):487-98. doi: 10.1158/1078-0432.CCR-11-1440. Epub 2011 Nov 29.
5
ABT-737 increases tyrosine kinase inhibitor-induced apoptosis in chronic myeloid leukemia cells through XIAP downregulation and sensitizes CD34(+) CD38(-) population to imatinib.
Exp Hematol. 2012 May;40(5):367-78.e2. doi: 10.1016/j.exphem.2012.01.004. Epub 2012 Jan 10.
6
Mcl-1 down-regulation potentiates ABT-737 lethality by cooperatively inducing Bak activation and Bax translocation.
Cancer Res. 2007 Jan 15;67(2):782-91. doi: 10.1158/0008-5472.CAN-06-3964.
7
Mechanism of synergy of N-(4-hydroxyphenyl)retinamide and ABT-737 in acute lymphoblastic leukemia cell lines: Mcl-1 inactivation.
J Natl Cancer Inst. 2008 Apr 16;100(8):580-95. doi: 10.1093/jnci/djn076. Epub 2008 Apr 8.
8
Co-targeting of Bcl-2 and mTOR pathway triggers synergistic apoptosis in BH3 mimetics resistant acute lymphoblastic leukemia.
Oncotarget. 2015 Oct 13;6(31):32089-103. doi: 10.18632/oncotarget.5156.
9
Mechanisms of antileukemic activity of the novel Bcl-2 homology domain-3 mimetic GX15-070 (obatoclax).
Cancer Res. 2008 May 1;68(9):3413-20. doi: 10.1158/0008-5472.CAN-07-1919.
10
BH3 mimetic ABT-737 and a proteasome inhibitor synergistically kill melanomas through Noxa-dependent apoptosis.
J Invest Dermatol. 2009 Apr;129(4):964-71. doi: 10.1038/jid.2008.327. Epub 2008 Nov 6.
引用本文的文献
1
Circumvention of Mcl-1-dependent drug resistance by simultaneous Chk1 and MEK1/2 inhibition in human multiple myeloma cells.
PLoS One. 2014 Mar 4;9(3):e89064. doi: 10.1371/journal.pone.0089064. eCollection 2014.
2
Transcription inhibition as a therapeutic target for cancer.
Cancers (Basel). 2011 Nov 23;3(4):4170-90. doi: 10.3390/cancers3044170.
3
Advances in the development of nucleoside and nucleotide analogues for cancer and viral diseases.
Nat Rev Drug Discov. 2013 Jun;12(6):447-64. doi: 10.1038/nrd4010.
4
Novel leukemic cell lines resistant to clofarabine by mechanisms of decreased active metabolite and increased antiapoptosis.
Cancer Sci. 2013 Jun;104(6):732-9. doi: 10.1111/cas.12131. Epub 2013 Apr 3.
5
Understanding sensitivity to BH3 mimetics: ABT-737 as a case study to foresee the complexities of personalized medicine.
J Mol Signal. 2012 Aug 16;7(1):12. doi: 10.1186/1750-2187-7-12.
6
ARC synergizes with ABT-737 to induce apoptosis in human cancer cells.
Mol Cancer Ther. 2010 Jun;9(6):1688-96. doi: 10.1158/1535-7163.MCT-09-0919. Epub 2010 Jun 1.
本文引用的文献
1
ARC (NSC 188491) has identical activity to Sangivamycin (NSC 65346) including inhibition of both P-TEFb and PKC.
BMC Cancer. 2009 Feb 20;9:63. doi: 10.1186/1471-2407-9-63.
2
Novel anticancer compounds induce apoptosis in melanoma cells.
Cell Cycle. 2008 Jun 15;7(12):1851-5. doi: 10.4161/cc.7.12.6032. Epub 2008 Jun 30.
3
Differential sensitivity of human colon cancer cell lines to the nucleoside analogs ARC and DRB.
Int J Cancer. 2008 Mar 15;122(6):1426-9. doi: 10.1002/ijc.23239.
4
Proapoptotic compound ARC targets Akt and N-myc in neuroblastoma cells.
Oncogene. 2008 Jan 24;27(5):694-9. doi: 10.1038/sj.onc.1210692. Epub 2007 Sep 3.
5
Mcl-1 down-regulation potentiates ABT-737 lethality by cooperatively inducing Bak activation and Bax translocation.
Cancer Res. 2007 Jan 15;67(2):782-91. doi: 10.1158/0008-5472.CAN-06-3964.
6
A novel transcriptional inhibitor induces apoptosis in tumor cells and exhibits antiangiogenic activity.
Cancer Res. 2006 Mar 15;66(6):3264-70. doi: 10.1158/0008-5472.CAN-05-3940.
7
An inhibitor of Bcl-2 family proteins induces regression of solid tumours.
Nature. 2005 Jun 2;435(7042):677-81. doi: 10.1038/nature03579. Epub 2005 May 15.
8
Transcriptional and translational control of Mcl-1 during apoptosis.
Arch Biochem Biophys. 2003 Sep 15;417(2):141-52. doi: 10.1016/s0003-9861(03)00345-x.
Zotero 插件